<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/A/Alemtuzumab.html">
<title>Alemtuzumab RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/A/Alemtuzumab.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2012-01-24T22:32+06:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Alemtuzumab RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/alemtuzumab/statuses/161506121755009027" />
  <rdf:li rdf:resource="http://twitter.com/alemtuzumab/statuses/161505634498510848" />
  <rdf:li rdf:resource="http://twitter.com/CardiologiaF/statuses/161485132597960704" />
  <rdf:li rdf:resource="http://twitter.com/Cecilrvt/statuses/161338902433640450" />
  <rdf:li rdf:resource="http://twitter.com/Dronurk/statuses/161131813199290368" />
  <rdf:li rdf:resource="http://twitter.com/yousef_418/statuses/160834528577986560" />
  <rdf:li rdf:resource="http://twitter.com/cardiacimaging/statuses/160764572154859520" />
  <rdf:li rdf:resource="http://twitter.com/Migraine_Wisdom/statuses/160560146311938048" />
  <rdf:li rdf:resource="http://twitter.com/HypertensionBio/statuses/160195361833623554" />
  <rdf:li rdf:resource="http://twitter.com/Dermatology_bio/statuses/160190838180286464" />
  <rdf:li rdf:resource="http://twitter.com/stemcellnews/statuses/160190401406447617" />
  <rdf:li rdf:resource="http://twitter.com/blood_bio/statuses/160187976889016320" />
  <rdf:li rdf:resource="http://twitter.com/SianGwilym/statuses/160028446561546240" />
  <rdf:li rdf:resource="http://twitter.com/EGraphidecum/statuses/160016036928827392" />
  <rdf:li rdf:resource="http://twitter.com/masquemedicos/statuses/160001898508857344" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/alemtuzumab/statuses/161506121755009027">
<title>Bu da abimizden &#xC3;&#xA7;&#xC4;&#xB1;kan cam par&#xC3;&#xA7;as&#xC4;&#xB1;....... http://t.co/AgBEzqmh</title>
<link>http://twitter.com/alemtuzumab/statuses/161506121755009027</link>
<description><![CDATA[Bu da abimizden çıkan cam parçası....... http://t.co/AgBEzqmh]]></description>
</item>

<item rdf:about="http://twitter.com/alemtuzumab/statuses/161505634498510848">
<title>Cam&#xC4;&#xB1; yumruklayan bir abimizin kesik yeri... &#xC4;&#xB0;&#xC3;&#xA7;inden &#xC3;&#xA7;&#xC4;&#xB1;kan cam par&#xC3;&#xA7;as&#xC4;&#xB1;n&#xC4;&#xB1;n foto&#xC4;&#x9F;raf&#xC4;&#xB1; az sonra http://t.co/yjE2FOGr</title>
<link>http://twitter.com/alemtuzumab/statuses/161505634498510848</link>
<description><![CDATA[Camı yumruklayan bir abimizin kesik yeri... İçinden çıkan cam parçasının fotoğrafı az sonra http://t.co/yjE2FOGr]]></description>
</item>

<item rdf:about="http://twitter.com/CardiologiaF/statuses/161485132597960704">
<title>Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Resonance... http://t.co/3ZHcaRvV</title>
<link>http://twitter.com/CardiologiaF/statuses/161485132597960704</link>
<description><![CDATA[Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Resonance... http://t.co/3ZHcaRvV]]></description>
</item>

<item rdf:about="http://twitter.com/Cecilrvt/statuses/161338902433640450">
<title>Genzyme Presents New Data From Alemtuzumab Phase 2 _MS_ Trial At 63rd Annual Meeting Of The American Academy Of... http://t.co/iK1vrDId</title>
<link>http://twitter.com/Cecilrvt/statuses/161338902433640450</link>
<description><![CDATA[Genzyme Presents New Data From Alemtuzumab Phase 2 _MS_ Trial At 63rd Annual Meeting Of The American Academy Of... http://t.co/iK1vrDId]]></description>
</item>

<item rdf:about="http://twitter.com/Dronurk/statuses/161131813199290368">
<title>Alemtuzumab CD52 antikoru KLL tdvsnde kullan&#xC4;&#xB1;l&#xC4;&#xB1;r</title>
<link>http://twitter.com/Dronurk/statuses/161131813199290368</link>
<description><![CDATA[Alemtuzumab CD52 antikoru KLL tdvsnde kullanılır]]></description>
</item>

<item rdf:about="http://twitter.com/yousef_418/statuses/160834528577986560">
<title>Treatment of choice is extracorporeal photophoresis.Phototherapy ortotal skin electron beam + interferone.Bexarotene,vorinastat,alemtuzumab.</title>
<link>http://twitter.com/yousef_418/statuses/160834528577986560</link>
<description><![CDATA[Treatment of choice is extracorporeal photophoresis.Phototherapy ortotal skin electron beam + interferone.Bexarotene,vorinastat,alemtuzumab.]]></description>
</item>

<item rdf:about="http://twitter.com/cardiacimaging/statuses/160764572154859520">
<title>Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Seria... http://t.co/MkYI74hP #imaging</title>
<link>http://twitter.com/cardiacimaging/statuses/160764572154859520</link>
<description><![CDATA[Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Seria... http://t.co/MkYI74hP #imaging]]></description>
</item>

<item rdf:about="http://twitter.com/Migraine_Wisdom/statuses/160560146311938048">
<title>Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Reson... http://t.co/cShF7tqN</title>
<link>http://twitter.com/Migraine_Wisdom/statuses/160560146311938048</link>
<description><![CDATA[Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Reson... http://t.co/cShF7tqN]]></description>
</item>

<item rdf:about="http://twitter.com/HypertensionBio/statuses/160195361833623554">
<title>BioPortfolio News News Infection risk not increased with alemtuzumab: Alemtuzumab clears circu... http://t.co/xeZbnefL BioPortfolio News</title>
<link>http://twitter.com/HypertensionBio/statuses/160195361833623554</link>
<description><![CDATA[BioPortfolio News News Infection risk not increased with alemtuzumab: Alemtuzumab clears circu... http://t.co/xeZbnefL BioPortfolio News]]></description>
</item>

<item rdf:about="http://twitter.com/Dermatology_bio/statuses/160190838180286464">
<title>BioPortfolio News News Infection risk not increased with alemtuzumab: Alemtuzumab clears circu... http://t.co/RuojYLiQ BioPortfolio News</title>
<link>http://twitter.com/Dermatology_bio/statuses/160190838180286464</link>
<description><![CDATA[BioPortfolio News News Infection risk not increased with alemtuzumab: Alemtuzumab clears circu... http://t.co/RuojYLiQ BioPortfolio News]]></description>
</item>

<item rdf:about="http://twitter.com/stemcellnews/statuses/160190401406447617">
<title>BioPortfolio News News Infection risk not increased with alemtuzumab: Alemtuzumab clears circu... http://t.co/G961A7Ym BioPortfolio News</title>
<link>http://twitter.com/stemcellnews/statuses/160190401406447617</link>
<description><![CDATA[BioPortfolio News News Infection risk not increased with alemtuzumab: Alemtuzumab clears circu... http://t.co/G961A7Ym BioPortfolio News]]></description>
</item>

<item rdf:about="http://twitter.com/blood_bio/statuses/160187976889016320">
<title>News Infection risk not increased with alemtuzumab: Alemtuzumab clears circulating B and T lymphocytes and effec... http://t.co/raY3ghg4</title>
<link>http://twitter.com/blood_bio/statuses/160187976889016320</link>
<description><![CDATA[News Infection risk not increased with alemtuzumab: Alemtuzumab clears circulating B and T lymphocytes and effec... http://t.co/raY3ghg4]]></description>
</item>

<item rdf:about="http://twitter.com/SianGwilym/statuses/160028446561546240">
<title>My latest instalment on my Alemtuzumab treatment - Alemtuzumab, MS and me: Week seven and eight after the Big A http://t.co/xg6NxIK4</title>
<link>http://twitter.com/SianGwilym/statuses/160028446561546240</link>
<description><![CDATA[My latest instalment on my Alemtuzumab treatment - Alemtuzumab, MS and me: Week seven and eight after the Big A http://t.co/xg6NxIK4]]></description>
</item>

<item rdf:about="http://twitter.com/EGraphidecum/statuses/160016036928827392">
<title>Razones de la eficacia alemtuzumab en linfoma de c&#xC3;&#xA9;lulas T http://t.co/Y5mqQOxm</title>
<link>http://twitter.com/EGraphidecum/statuses/160016036928827392</link>
<description><![CDATA[Razones de la eficacia alemtuzumab en linfoma de células T http://t.co/Y5mqQOxm]]></description>
</item>

<item rdf:about="http://twitter.com/masquemedicos/statuses/160001898508857344">
<title>La efectividad de Alemtuzumab #medicamento para el tratamiento de la leucemia http://t.co/T8No1IXW</title>
<link>http://twitter.com/masquemedicos/statuses/160001898508857344</l
